ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 673104 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 673104; 2) Community: the network communities that were significantly associated with the response to NSC 673104; 3) Molecule: the relationships between components within communities and NSC 673104; 4) MDR: the compounds that were significantly associated with the NSC 673104.

NSC Compound Enrichment Correlation
NSC 642915 Null 0.042089336762887 0.045013771
NSC 656211 Null 0.042089336762887 -0.24534827
NSC 683557 Camptothecin Derivative 0.0420893367628876 0.025184953
NSC 700582 [1,2,3,4]tetrathiocino[5,6-d:7,8-d']diimidazole -2,9-dithione, 1,3,8,10-tetrabutyl-1,2,3,8,9,10-hexahydro- 0.0420893367628876 -0.027852897
NSC 734758 Null 0.0420893367628876 -0.038995985
NSC 746248 Null 0.0420893367628876 0.11211792
NSC 753772 Null 0.0420893367628876 -0.18729281
NSC 95099 Bigitalin 0.0420893367628876 -0.051872459
NSC 676774 Olean-12-en-28-oic acid, 3-.beta.-[2-O-(.beta.-D-glucopyranosyl)- .beta.-D-glucopyranosyloxy]-, [2-O-[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-6-deoxy-.beta.-D-gulopyranosyl]- .b 0.0430277102950697 -0.27873056
NSC 676775 Olean-12-en-28-oic acid, 3-.beta.-[2-O-(.beta.-D-glucopyranosyl)- .beta.-D-glucopyranosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-.beta.-D-xylopyranosyl]- 6-deo 0.0430277102950697 -0.38606344
Total:50  Current:46    [First] [Prev] [Next] [Last]